Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.
Baba T, Sakai F, Kato T, Kusumoto M, Kenmotsu H, Sugiura H, Tominaga J, Oikado K, Sata M, Endo M, Yanagawa N, Sasaki S, Iwasawa T, Saito Y, Fujiwara Y, Ohe Y, Yamazaki N, Sakamoto T, Koshiba T, Kuwano K. Baba T, et al. Among authors: sakamoto t. Future Oncol. 2019 Jun;15(16):1911-1920. doi: 10.2217/fon-2019-0102. Epub 2019 Apr 25. Future Oncol. 2019. PMID: 31020849
Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer.
Saito Y, Sasaki S, Oikado K, Tominaga J, Sata M, Sakai F, Kato T, Iwasawa T, Kenmotsu H, Kusumoto M, Baba T, Endo M, Fujiwara Y, Sugiura H, Yanagawa N, Ito Y, Sakamoto T, Ohe Y, Kuwano K. Saito Y, et al. Among authors: sakamoto t. Cancer Sci. 2021 Apr;112(4):1495-1505. doi: 10.1111/cas.14710. Epub 2021 Feb 24. Cancer Sci. 2021. PMID: 33098725 Free PMC article.
Treatment and relapse of interstitial lung disease in nivolumab-treated patients with non-small cell lung cancer.
Sata M, Sasaki S, Oikado K, Saito Y, Tominaga J, Sakai F, Kato T, Iwasawa T, Kenmotsu H, Kusumoto M, Baba T, Endo M, Fujiwara Y, Sugiura H, Yanagawa N, Ito Y, Sakamoto T, Ohe Y, Kuwano K. Sata M, et al. Among authors: sakamoto t. Cancer Sci. 2021 Apr;112(4):1506-1513. doi: 10.1111/cas.14715. Epub 2021 Feb 24. Cancer Sci. 2021. PMID: 33125784 Free PMC article.
Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.
Takagi Y, Hosomi Y, Oshita F, Okamoto H, Seki N, Minato K, Aono H, Yamada K, Okuma Y, Hida N, Sakamoto T, Miura Y, Yomota M, Satoh A, Kunitoh H, Sakamaki K, Shibuya M, Watanabe K. Takagi Y, et al. Among authors: sakamoto t. BMC Cancer. 2015 Oct 19;15:740. doi: 10.1186/s12885-015-1756-1. BMC Cancer. 2015. PMID: 26481215 Free PMC article. Clinical Trial.
Paraneoplastic IgA Vasculitis in an Adult with Lung Adenocarcinoma.
Ota S, Haruyama T, Ishihara M, Natsume M, Fukasawa Y, Sakamoto T, Tanzawa S, Usui R, Honda T, Ichikawa Y, Watanabe K, Sasajima Y, Seki N. Ota S, et al. Among authors: sakamoto t. Intern Med. 2018 May 1;57(9):1273-1276. doi: 10.2169/internalmedicine.9651-17. Epub 2017 Dec 27. Intern Med. 2018. PMID: 29279496 Free PMC article.
Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a retrospective, observational study.
Chen H, Yamane T, Haruyama T, Ishihara M, Kazahari H, Sakamoto T, Tanzawa S, Honda T, Ichikawa Y, Watanabe K, Seki N. Chen H, et al. Among authors: sakamoto t. Transl Cancer Res. 2023 Dec 31;12(12):3538-3546. doi: 10.21037/tcr-23-1217. Epub 2023 Dec 5. Transl Cancer Res. 2023. PMID: 38192991 Free PMC article.
5,434 results